This study identified metrics to evaluate the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) program. The SBIR program is structured in three phases: Feasibility; Full Research/Research and Development Effort; and, Commercialization without SBIR funds. The Metric Team selected two overlapping sets of metrics for the NCI SBIR program: one set based on innovation or the creation and dissemination of science-based discoveries intended for the market and the other based on commercialization or the process of getting innovations into the marketplace. The team then used the measures to analyze national survey data and compare the performance of the NCI SBIR program to all other NIH SBIR programs.
The team found that the NCI program performed similarly to all other NIH SBIR programs across the innovation and commercialization metrics they had selected. For future implementation of the metrics, the NCI Metric Team recommended that NCI support more robust data gathering by supporting NIH-wide data collection efforts; creating an NCI commercialization database; and collecting information on commercialization from awardees.
Report Title: Metrics for NCI SBIR Program
Agency Sponsor: NIH, National Institutes of Health
Federal Contact: Rosanna Ng, 301-496-5367
Performer: Humanitas, Inc.
Record ID: 9399 (Report issued June 30, 2010)